@toby_the_dog
Per patient imports
If a medical practitioner considers a medicinal cannabis product to be suitable for a particular patient, they must first seek approval from the TGA under the Special Access Scheme (SAS) or be granted 'Authorised Prescriber' (AP) status by the TGA. The doctor must also ensure the product and treatment is approved under the law of the state or territory in which the patient resides, as well as get TGA approvals. Evidence of these approvals may be required for the import application to the Office of Drug Control.
Once the doctor obtains SAS approval or is an Authorised Prescriber and can demonstrate the product and treatment is permissible under state or territory law, they (or a person on their behalf) can seek permission to import by completing relevant licence and permit application forms.
https://www.odc.gov.au/import-and-export
Prior to the changes, any unregistered therapeutic goods can potentially be supplied via the SAS Category A process,
except for:
1. Prohibited substances in Schedule 9 of the Poisons Standard; and
2. medicinal cannabis products.
.........'enable terminally ill patients to access medicinal cannabis products through the
TGA SAS Category A process...The
medical practitioner completes the relevant
Category A form and sends it to the supplier of the product and a copy to the TGA. This provides the supplier, such as
AusCann, with the legal authority to supply the product.'
Try bring any drug into the country without the correct approval and it will be rejected. AusCann seems to have positioned itself in the correct manner and ready to distribute and supply. Q3-4 will be very interesting as I'm 90% sure most people seeking the treatment will be looking for the cure within Australia rather then overseas (delays).
All the info is out there.
Best
